Home
About
Overview
Sharing Data
ORCID
Help
History (3)
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease.
A simple validated clinical tool to predict the absence of coronary artery disease in patients with systolic heart failure of unclear etiology.
Real-time myocardial perfusion contrast echocardiography and regional wall motion abnormalities after aneurysmal subarachnoid hemorrhage. Clinical article.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease.
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med. 2005 May; 11(5):551-5.
View in:
PubMed
subject areas
Aged
Alzheimer Disease
Cholinergic Fibers
Cognition
Fibroblasts
Fluorodeoxyglucose F18
Genetic Therapy
Histological Techniques
Humans
Middle Aged
Nerve Growth Factor
Neuropsychological Tests
Positron-Emission Tomography
Prosencephalon
authors with profiles
Roy Bakay
Elliott Mufson
Jeffrey Kordower